{"filing":{"accession_number":"0001829126-26-009860","cik":"0002109869","ticker":null,"company_name":"Exascale Labs Holdings Inc.","form":"8-K","filing_date":"2026-09-08","report_date":"2026-09-04","primary_document":"exascalelabs_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2109869/000182912626009860/exascalelabs_8k.htm"},"events":[{"id":31907,"run_id":29304,"accession_number":"0001829126-26-009860","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Gildas Bonnier as Interim Chief Financial Officer effective September 4, 2026. Although the role is interim and a permanent CFO search is underway, the appointment of a principal financial officer is a material executive appointment that would affect investor assessment of the company's financial leadership and governance. The detailed biographical information and compensation terms ($10,000/month consulting fee) confirm this is a substantive appointment disclosure.","company_name":"Exascale Labs Holdings Inc.","ticker":null,"filing_date":"2026-09-08","form":"8-K","submitted_at":null,"items":[{"id":34941,"accession_number":"0001829126-26-009860","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Gildas Bonnier as Interim Chief Financial Officer effective September 4, 2026. Although the role is interim and a permanent CFO search is underway, the appointment of a principal financial officer is a material executive appointment that would affect investor assessment of the company's financial leadership and governance. The detailed biographical information and compensation terms ($10,000/month consulting fee) confirm this is a substantive appointment disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T16:36:36.494799+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34941,"accession_number":"0001829126-26-009860","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Gildas Bonnier as Interim Chief Financial Officer effective September 4, 2026. Although the role is interim and a permanent CFO search is underway, the appointment of a principal financial officer is a material executive appointment that would affect investor assessment of the company's financial leadership and governance. The detailed biographical information and compensation terms ($10,000/month consulting fee) confirm this is a substantive appointment disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T16:36:36.494799+00:00","company_name":"Exascale Labs Holdings Inc.","ticker":null,"filing_date":"2026-09-08"}]}